Market Cap 142.94B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.24
Forward PE 8.44
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 82,009,211
Avg Vol 37,858,195
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 2%
Beta 0.34
Analysts Sell
Price Target $29.28

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Longshot606
Longshot606 Jun. 24 at 12:52 AM
$PFE Been holding for a few years. Tired of it. Sure the dividend is nice but so many better plays in pharma. Struggling with why to stay in. Frustrated. Can anyone give me a good reason not to sell besides dividend?
1 · Reply
Zero12345
Zero12345 Jun. 24 at 12:44 AM
$PFE Failed, scrapped, in the toilet... WTF
0 · Reply
BarbaraSmith247
BarbaraSmith247 Jun. 24 at 12:05 AM
$PFE $BMNR $KVYO $CRMD $ZVRA shows signs of semiconductor cycle view. I am holding through noise while watching key levels and sentiment shifts.
0 · Reply
biolover
biolover Jun. 24 at 12:02 AM
$VKTX I think valuation gap was $PFE Bourla problem and he is paying for his stance now. Serious parties that want to compete with $LLY evaluate asset value and once they agree they come up with a journal report to close the gap. I don’t believe $NVO is worried about premium vs getting right asset. Same applies to several others. Something is serious brewing.
1 · Reply
MarketVisionn1
MarketVisionn1 Jun. 23 at 11:37 PM
My position in $TSLA $CRML $SQQQ $PFE is based on long-term conviction holding. Volatility is expected, but the structure still looks intact.
0 · Reply
Ro_Patel
Ro_Patel Jun. 23 at 11:28 PM
Today's option volume of 67.2K contracts was -13.00% below recent avg levels, w/ calls leading puts 9 to 8 ETF & index products saw relatively heavy volume, while single stock flow was moderate. Today's most active sectors included Health Care, Basic Materials, & Utilities, while Consumer Non-Cyclicals & Industrials were relatively light. Among the 500 most liquid single stocks, 30day IV was higher for 185 & lower for 263 Unusual total option volume was observed in $DRAM $PFE $JD $NVO & $PCG
0 · Reply
Dagrinch
Dagrinch Jun. 23 at 11:11 PM
$PFE i have my sells locked on draftkings just tell a white lie take my shares then dump lmao
0 · Reply
Dagrinch
Dagrinch Jun. 23 at 11:09 PM
$PFE just lie like you always have so my man pothead can get the fuck out
0 · Reply
Dagrinch
Dagrinch Jun. 23 at 11:08 PM
$PFE im not a pretender my butt hurts bad how does moderna double on a flue vaccine and we have same technology and 24.50 lmao
1 · Reply
capitalthinktank
capitalthinktank Jun. 23 at 10:35 PM
Building $150K$200K/year in dividends isn’t about chasing yield - it’s about owning cash-flowing businesses that consistently return capital. Names like $VZ, $MO, $O, $PFE, and income vehicles like $SCHD and JEPI are sitting in that 5–8% yield range right now. The real engine isn’t the yield itself - it’s what you do with it. DCA into positions, reinvest through DRIP, and let compounding quietly scale over time. It’s slow. It’s boring. But that’s exactly why it works when it’s done correctly.
0 · Reply
Latest News on PFE
Pfizer (PFE) Shares Sink After Surprise CFO Exit

2026-06-18T18:35:11.000Z - 5 days ago

Pfizer (PFE) Shares Sink After Surprise CFO Exit


Pfizer reaffirms all components of FY26 guidance

2026-06-18T17:30:31.000Z - 5 days ago

Pfizer reaffirms all components of FY26 guidance


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 5 days ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 5 days ago

Pfizer Announces Chief Financial Officer Transition


Pfizer says FDA approves expanded indication for Hympavzi

2026-06-08T10:51:57.000Z - 15 days ago

Pfizer says FDA approves expanded indication for Hympavzi


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 15 days ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer presents results from Phase 2b studies of berobenatide

2026-06-07T22:00:49.000Z - 16 days ago

Pfizer presents results from Phase 2b studies of berobenatide


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 17 days ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 17 days ago

Pfizer Slides: Study update


Mailbag: A Follow-Up on Pfizer & Other Questions

May 30, 2026, 9:22 AM EDT - 24 days ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA


Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 7 weeks ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC


Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 7 weeks ago

Pfizer CEO on AI-designed molecule, and race to use new tech


3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 7 weeks ago

3 Dividend Stocks for May 2026

SYY WSO


Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Earnings Call Transcript: Q1 2026


Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Earnings release: Q1 2026


Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Quarterly report: Q1 2026


Pfizer Slides: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Slides: Q1 2026


Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 7 weeks ago

Pfizer Posts Better-Than-Expected Revenue, Profit


Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 7 weeks ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS


US FDA approves Pfizer, Arvinas' breast cancer drug

May 1, 2026, 12:37 PM EDT - 7 weeks ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN


Pfizer's blood cancer drug meets main goal in late-stage trial

Apr 29, 2026, 7:42 AM EDT - 7 weeks ago

Pfizer's blood cancer drug meets main goal in late-stage trial


Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 28, 2026, 10:17 AM EDT - 2 months ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX


Longshot606
Longshot606 Jun. 24 at 12:52 AM
$PFE Been holding for a few years. Tired of it. Sure the dividend is nice but so many better plays in pharma. Struggling with why to stay in. Frustrated. Can anyone give me a good reason not to sell besides dividend?
1 · Reply
Zero12345
Zero12345 Jun. 24 at 12:44 AM
$PFE Failed, scrapped, in the toilet... WTF
0 · Reply
BarbaraSmith247
BarbaraSmith247 Jun. 24 at 12:05 AM
$PFE $BMNR $KVYO $CRMD $ZVRA shows signs of semiconductor cycle view. I am holding through noise while watching key levels and sentiment shifts.
0 · Reply
biolover
biolover Jun. 24 at 12:02 AM
$VKTX I think valuation gap was $PFE Bourla problem and he is paying for his stance now. Serious parties that want to compete with $LLY evaluate asset value and once they agree they come up with a journal report to close the gap. I don’t believe $NVO is worried about premium vs getting right asset. Same applies to several others. Something is serious brewing.
1 · Reply
MarketVisionn1
MarketVisionn1 Jun. 23 at 11:37 PM
My position in $TSLA $CRML $SQQQ $PFE is based on long-term conviction holding. Volatility is expected, but the structure still looks intact.
0 · Reply
Ro_Patel
Ro_Patel Jun. 23 at 11:28 PM
Today's option volume of 67.2K contracts was -13.00% below recent avg levels, w/ calls leading puts 9 to 8 ETF & index products saw relatively heavy volume, while single stock flow was moderate. Today's most active sectors included Health Care, Basic Materials, & Utilities, while Consumer Non-Cyclicals & Industrials were relatively light. Among the 500 most liquid single stocks, 30day IV was higher for 185 & lower for 263 Unusual total option volume was observed in $DRAM $PFE $JD $NVO & $PCG
0 · Reply
Dagrinch
Dagrinch Jun. 23 at 11:11 PM
$PFE i have my sells locked on draftkings just tell a white lie take my shares then dump lmao
0 · Reply
Dagrinch
Dagrinch Jun. 23 at 11:09 PM
$PFE just lie like you always have so my man pothead can get the fuck out
0 · Reply
Dagrinch
Dagrinch Jun. 23 at 11:08 PM
$PFE im not a pretender my butt hurts bad how does moderna double on a flue vaccine and we have same technology and 24.50 lmao
1 · Reply
capitalthinktank
capitalthinktank Jun. 23 at 10:35 PM
Building $150K$200K/year in dividends isn’t about chasing yield - it’s about owning cash-flowing businesses that consistently return capital. Names like $VZ, $MO, $O, $PFE, and income vehicles like $SCHD and JEPI are sitting in that 5–8% yield range right now. The real engine isn’t the yield itself - it’s what you do with it. DCA into positions, reinvest through DRIP, and let compounding quietly scale over time. It’s slow. It’s boring. But that’s exactly why it works when it’s done correctly.
0 · Reply
notreload_ai
notreload_ai Jun. 23 at 9:37 PM
$NKE named David Denton from $PFE as its new CFO starting August 17, replacing Matthew Friend. Denton was Pfizer’s finance chief since 2022 and earlier CFO at Lowe’s and CVS. Nike is struggling with its turnaround amid stiff competition and supply chain issues. https://www.wsj.com/business/c-suite/nike-names-pfizers-denton-as-next-cfo-ff46a44b?eafs_enabled=false
0 · Reply
FutureInvestorr1
FutureInvestorr1 Jun. 23 at 9:37 PM
$WYFI $PFE $QBTS is trading in a way that reflects AI momentum continuation. I am staying disciplined and letting the chart confirm the narrative.
1 · Reply
Bobbyg996
Bobbyg996 Jun. 23 at 9:23 PM
$NKE $PFE - That’s funny. I bought both NKE and PFE today, lol
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 9:21 PM
Biotech's Silent Resurgence $XBI $IBB $NVS $PFE $LLY $IBB https://www.zacks.com/commentary/2941732/biotechs-silent-resurgence-5-year-base-breakout?art_rec=home-home-top_stories-ID02-img-2941732&cid=sm-stocktwits-1-2941732-teaser-38503&ADID=SYND_STOCKTWITS_TWEET_1_2941732_TEASER_38503
1 · Reply
bhall68
bhall68 Jun. 23 at 9:15 PM
$PFE I am so glad I’m out of that stock and out of that company. Albert Bourla has ran that company into the ground. No vision. He has no business in being a CEO. He’s a freaking vet. What a joke. They are paying a hell of a dividend. That’s the only way anyone would own the stock. This is at the same level as several decades ago. Decades! Not years. This is a corrupt example of a BOD. They just keep getting paid while shareholders suffer for years.
1 · Reply
Jtlo
Jtlo Jun. 23 at 8:52 PM
$NKE $PFE lol another L why did i come back to youuuu
1 · Reply
DidYouReadThis
DidYouReadThis Jun. 23 at 8:31 PM
DD super readers, what companies to you predict to be a potential buy out target by 2030 whether by $PFE, $RHHBY $ABBV $LLY or a different co?
0 · Reply
AlphaGeneral
AlphaGeneral Jun. 23 at 8:24 PM
I am seeing risk management focus in $NOK $COIN $PFE $BTQ $DKNG. Not reacting emotionally, just observing price action and volume behavior across sessions.
0 · Reply
_Crim_Jamer_
_Crim_Jamer_ Jun. 23 at 8:15 PM
$PFE i tried to type green close, but then I waited 3 minutes.
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jun. 23 at 8:09 PM
$PFE Albert has been doing such a good job that I went in 100% today. Cant even buy one more share. What's the point of diversification if you've got an incredible ceo like big Al?
1 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 23 at 7:56 PM
$PFE why wouldn’t it be a sell into close as well?????
2 · Reply
MrPeanutEsquire
MrPeanutEsquire Jun. 23 at 7:54 PM
$PFE Another day beaten by the boats....
0 · Reply